Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132882A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007WO2007132801A1 Stent
11/22/2007WO2007132555A1 Cell membrane-permeable peptide and utilization of the same in cell
11/22/2007WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007WO2007132054A1 New use of therapeutically useful peptides
11/22/2007WO2007132037A1 Method for synthesizing thymosins
11/22/2007WO2007131966A1 Macrocyclic compounds as antiviral agents
11/22/2007WO2007131424A1 Method for preparing low molecular weight proteoglycan and collagen compositions, its products and uses
11/22/2007WO2007131352A1 High-affinity antagonists of elr-cxc chemokines
11/22/2007WO2007131300A1 Polypeptides and polynucleotides encoding the same
11/22/2007WO2007131286A1 Nanostructures suitable for delivery of agents
11/22/2007WO2007131280A1 HEMATOPOIESIS AND REGULATION THEREOF BY ETS RELATED GENE (Erg)
11/22/2007WO2007104932A3 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
11/22/2007WO2007104173A3 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
11/22/2007WO2007102140A3 A semliki forest virus replication competent vector with enhanced biosafety
11/22/2007WO2007101949A3 Human interferon-gamma (infgamma) variants
11/22/2007WO2007100695A9 Metabolic regulators and uses thereof
11/22/2007WO2007091267A3 Pulmonary delivery of alpha-i proteinase inhibitor
11/22/2007WO2007090022A3 Novel compounds for targeting endothelial cells, compositions containing the same and methods for their use
11/22/2007WO2007087572A3 Aza-peptide epoxides
11/22/2007WO2007084808A3 Methods of preparing activated polymers having alpha nitrogen groups
11/22/2007WO2007084670A3 Specific therapy using integrin ligands for treating cancer
11/22/2007WO2007075839A3 Glucagon injector for emergency treatment of hypoglycemia
11/22/2007WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007WO2007064882A3 Treatment of conditions involving demyelination
11/22/2007WO2007059470A3 Black bear parathyroid hormone and methods of using black bear parathyroid hormone
11/22/2007WO2007056422A3 Modulation of il-2 production by t-bet
11/22/2007WO2007053810A3 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
11/22/2007WO2007035716A3 Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
11/22/2007WO2007035640A3 Methods for reducing cd36 expression
11/22/2007WO2007033959A3 Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas
11/22/2007WO2007030556A3 An animal model for studying atherosclerotic lesions
11/22/2007WO2007027225A3 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/22/2007WO2007025247A3 Transglutaminase inhibitors and methods of use thereof
11/22/2007WO2006116410A3 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
11/22/2007WO2006079036A3 Methods and compositions for encapsulation of cells
11/22/2007WO2005123106A8 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester to treat sunburn and other burns
11/22/2007WO2005115479A3 Peptide conjugated, inosine-substituted antisense oligomer compound and method
11/22/2007WO2005091909A3 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (rpe) and bruch’s membrane (bm)
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005044995A3 Uses of human peptide deformylase
11/22/2007WO2005012547A3 Multimeric oxidoreductases
11/22/2007WO2004110365A3 Liver related disease compositions and methods
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007WO2001040484A3 A novel polypeptide, a human atp-dependent serine protease 64 and the polynucleotide encoding the polypeptide
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070271621 Nucleic acids encoding a chimeric glycosyltransferase
11/22/2007US20070270577 Genetic engineering; obtain cells, transform with vector containing protein, express vector, recover protein; contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired configurational isomer
11/22/2007US20070270575 Protein showing enhanced expression in cancer cells
11/22/2007US20070270506 Novel human kinases and polynucleotides encoding the same, and uses thereof
11/22/2007US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/22/2007US20070270489 Remedy for Cartilage-Related Diseases
11/22/2007US20070270480 Biphenyl Derived Thiamides as Calpain Inhibitors
11/22/2007US20070270464 Prodrugs of curcumin analogs
11/22/2007US20070270448 Methods of Using and Compositions Comprising a Jnk Inhibitor for the Treatment and Management of Asbestos-Related Diseases and Disorders
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270372 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested
11/22/2007US20070270369 An antisense nucleic acid or an small interfering RNA (siRNA) that inhibits interaction of survivin with hepatitis B X-interacting protein (HBXIP);modified backbone comprises phosphorothioates; antiapoptosis; anticarcinogenic agents; antitumor agents; viricides; tissue-targeted therapy
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070270360 Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
11/22/2007US20070270353 Intrathecal administration of ziconotide, an Omega-conopeptide, and the anitoxidant methionine, and an analgesic selected from morphine, hydromorphone, fentanyl, sufentanil, and buprenorphine; ziconotide retains its potency and is physically and chemically compatible with the analgesic
11/22/2007US20070270352 Method of Treatment
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270350 Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions
11/22/2007US20070270349 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
11/22/2007US20070270348 Compositions and Methods for Modulating Insulin-Activated Nitric Oxide Synthase
11/22/2007US20070270347 Methods of Treating Constipation by Administration of Nerve Growth Factor
11/22/2007US20070270346 Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
11/22/2007US20070270345 Periocular drug delivery for diabetic retinopathy
11/22/2007US20070270344 Compositions and methods for treating ophthalmic disorders
11/22/2007US20070270343 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors
11/22/2007US20070270342 Biotinylated hexadecasaccharides, preparation and use thereof
11/22/2007US20070270341 Parathyroid hormone analogues and methods of use
11/22/2007US20070270340 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
11/22/2007US20070270339 Use of GPCR54 Ligands for the Treatment of Infertility
11/22/2007US20070270338 prevention of cardiac cell death and prevention of cardiac tissue damage resulting from ischemic events in cardiac tissue; Cardiovascular disease such as angina, myocardial infarct (MI), and stroke
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070270336 Method for accelerating cutaneous barrier recovery
11/22/2007US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070270333 Methods of treating acute blood loss
11/22/2007US20070270332 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/22/2007US20070270331 Modulators of gluconeogenesis
11/22/2007US20070270330 Preventing airway mucus production by administration of egf-r antagonists
11/22/2007US20070270329 Derived from human glioma cells exhibiting monocyte chemotactic activity at a concentration of 1 nM, and exhibiting an estimated molecular mass of 8,400 daltons.
11/22/2007US20070269890 Inhibiting signaling by inhibiting palmitoylation; purified in presence of detergent to maintain solubility; maintenance and growth of stem cells, tissue regeneration
11/22/2007US20070269889 Stabilized siRNAs as transfection controls and silencing reagents
11/22/2007US20070269881 Carotene Synthase Gene and Uses Therefor
11/22/2007US20070269869 culturing under conditions effective to produce lipids lacking pigmentation from microorganisms Thraustochytriales, genetically modified to selectively delete or inactivate a carotene synthase gene comprising a nucleic acid sequence codes a protein havng phytoene dehydrogenase, lycopene cyclase activity
11/22/2007US20070269865 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269833 consisting of galectin-3 and chondroitin oligosaccharide and methods for seperating and detecting the chondroitin oligosaccharide in a sample using the immobilized complex
11/22/2007US20070269539 Ginkgo Biloba Extract as a Treatment for Therapeutic-Induced Neurotoxicity
11/22/2007US20070269531 Non-Steroid Anti-Inflammatory Agents with Vitamins, Minerals, and Dietary Supplements for the Prevention and Treatment of Primary, Secondary and Tertiary Cancer
11/22/2007US20070269528 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration
11/22/2007US20070269527 Therapeutic agents for low HDL-cholesterolemia
11/22/2007US20070269517 Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic Applications
11/22/2007US20070269504 Amphoteric liposomes
1 ... 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 ... 3163